DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Seletracetam
Seletracetam
Mechanisms of Action of Antiepileptic Drugs
PR2 2009.Vp:Corelventura
Pharmaceutical Composition Comprising Brivaracetam and Lacosamide with Synergistic Anticonvulsant Effect
Antiepileptic Potential of Ganaxolone Antiepileptički Potencijal Ganaksolona
Telemetric EEG and the Rat: a Guide for Neuroscientists
(12) Patent Application Publication (10) Pub. No.: US 2011/0021786 A1 Schenkel Et Al
Brivaracetam and Perampanel As Broad-Spectrum Antiseizure Drugs
Levetiracetam Inhibits Endocytosis and Augments Short-Term Depression
Stembook 2018.Pdf
Antiepileptic Potential of Ganaxolone Antiepileptički Potencijal Ganaksolona
Synthesis and Discovery of the Putative Cognitive Enhancer BRS- 015: Effect on Glutamatergic Transmission and Synaptic Plasticity
Seletracetam (UCB 44212)
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Poisons Standard February 2020
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Antiepileptic Medications
Briveracetam and Seletracetam – Two New Third-Generation Antiepileptic Drugs
Intramolecular Cyclization of N-Allyl Propiolamides: a Facile Synthetic Route to Highly Substituted G- Cite This: RSC Adv.,2017,7, 28407 Lactams (A Review)
Top View
Racetam Candidates Based on “Pyrrolidone” Dimers By: Robert B
And Chloride-Dependent GABA Transporter 1 and Docking Studies with Natural Compounds
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2016/014565 A2 28 January 2016 (28.01.2016) P O P C T
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Aniracetam Long Term Effects
Classification Status of Racetams
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The SV2A Ligand Levetiracetam Inhibits Presynaptic Ca Channels Via
(12) Patent Application Publication (10) Pub. No.: US 2015/0133488 A1 Deftereos Et Al
OMG Thesis Introduction
WO 2019/094724 Al 16 May 2019 (16.05.2019) W P O PCT
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
Patent Office
Integrative Systems Approaches Towards Brain Pharmacology and Polypharmacology
Press Release
World Journal of Pharmaceutical Research Sen Et Al
Drugs Affecting the Central Nervous System
(12) Patent Application Publication (10) Pub. No.: US 2009/017674.0 A1 Phillips, II (43) Pub
Publication of Interim Decisions Proposing to Amend, Or Not Amend, the Current Poisons Standard, February 2019
A Review of the Pharmacology and Clinical Efficacy of Brivaracetam
Recent Advances on Piracetam
Poisons Standard June 2021
Increased Compactibility of Acetames After Roll Compaction ⇑ Theresia Kuntz A, Martin A
The Epilepsy Research Benchmarks Progress Report